Response: Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors: how important is internal dosimetry?

  • I Lawal Universiteit van Pretoria
  • L Louw University of the Witwatersrand
  • J Warwick Stellenbosch University
  • N Nyakale University of KwaZulu-Natal
  • R Steyn University of Cape Town
  • T Lengana University of Pretoria
  • A Ellman Stellenbosch University
  • T Kotze University of Cape Town
  • M Vangu University of the Witwatersrand
  • M Vorster Universiteit van Pretoria
  • M Sathekge Universiteit van Pretoria
Keywords: internal dosimetry, PRRT

Abstract

We are grateful to Mr Trauernicht and Dr du Toit for their letter to the editor written on the recently published South African practice guidelines on peptide radionuclide therapy of neuroendocrine tumors.1 In the letter, they express concern that internal dosimetry was discussed in “only a single short paragraph” and that this may create an impression that “internal dosimetry assessment is just an optional extra.” The authors drew a contrast between the South African guidelines and the joint International Atomic Energy Agency (IAEA), European Association of Nuclear Medicine (EANM) and the Society of Nuclear Medicine and Molecular  Imaging guidelines published earlier where “a whole section on dosimetry” was included.2

Author Biographies

I Lawal, Universiteit van Pretoria

Department of Nuclear Medicine, University of Pretoria and Steve Biko Academic Hospital, Pretoria, South Africa

L Louw, University of the Witwatersrand

Department of Nuclear Medicine, Charlotte Maxeke Johannesburg Academic Hospital and University of the Witwatersrand, Johannesburg, South Africa

J Warwick, Stellenbosch University

Department of Nuclear Medicine, Tygerberg Academic Hospital and Stellenbosch University, Stellenbosch, South Africa

N Nyakale, University of KwaZulu-Natal

Department of Nuclear Medicine, Inkosi Albert Luthuli Central Hospital and University of KwaZulu-Natal, Durban, South Africa

R Steyn, University of Cape Town

Division of Nuclear Medicine, Groote Schuur Hospital and University of Cape Town, Cape Town South Africa

T Lengana, University of Pretoria

Department of Nuclear Medicine, University of Pretoria and Steve Biko Academic Hospital, Pretoria, South Africa

A Ellman, Stellenbosch University

Department of Nuclear Medicine, Tygerberg Academic Hospital and Stellenbosch University, Stellenbosch, South Africa

T Kotze, University of Cape Town

Division of Nuclear Medicine, Groote Schuur Hospital and University of Cape Town, Cape Town South Africa

M Vangu, University of the Witwatersrand

Department of Nuclear Medicine, Charlotte Maxeke Johannesburg Academic Hospital and University of the Witwatersrand, Johannesburg, South Africa

M Vorster, Universiteit van Pretoria

Department of Nuclear Medicine, University of Pretoria and Steve Biko Academic Hospital, Pretoria, South Africa

M Sathekge, Universiteit van Pretoria

Department of Nuclear Medicine, University of Pretoria and Steve Biko Academic Hospital, Pretoria, South Africa

Published
2019-03-29
How to Cite
Lawal, I., Louw, L., Warwick, J., Nyakale, N., Steyn, R., Lengana, T., Ellman, A., Kotze, T., Vangu, M., Vorster, M., & Sathekge, M. (2019). Response: Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors: how important is internal dosimetry?. South African Journal of Surgery, 57(1), 58-59. Retrieved from http://sajs.redbricklibrary.com/index.php/sajs/article/view/2956
Section
Letters to the Editor